Adeona to Host Second Quarter Investor Conference Call
Conference Call Scheduled for Monday, August 16, at 10:00 a.m. EDT
ANN ARBOR, Mich., Aug. 13 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc., (Amex: AEN), announced today that it will hold an investor conference call on Monday, August 16, 2010, at 10:00 a.m. EDT. James S. Kuo, M.D., M.B.A., Adeona's Chief Executive Officer, will host the call.
In order to participate in the conference call, please call toll free: 1-800-860-2442 (US); international dial-in: 1-412-858-4600; Canadian toll free: 1-866-605-3852. To ensure each participant is able to hear the conference call in its entirety, it is recommended that participants dial into the conference line 5 minutes prior to the call. The audio recording will be available for replay at http://www.adeonapharma.com for a period of at least 15 days after the call.
About Adeona Pharmaceuticals, Inc.
Adeona (Amex: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Our primary strategy is to license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to a valuation inflection point resulting in a significant development and marketing collaboration. We have four drug candidates and one medical food product candidate in clinical development. Further information on the company is available at www.adeonapharma.com
SOURCE Adeona Pharmaceuticals, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article